1Wilder Smith E, Kothbauer Margreiter I, Lammle B, et al. Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis. J Neurol Neurosurg Psychiatry, 1997, 63(3): 351-356.
2Kellett MW, Martin PJ, Enevoldson TP, et al. Cerebral venous sinus thrombosis associated with 20210A mutation of the prothrombin gene. J Neurol Neurosurg Psychiatry, 1998, 65(4): 611-612.
3van Krimpen J, Leebeek FW, Dippel DW, et al. Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis.Clin Neurol Neurosurg, 1999, 101 ( 1 ): 53-55.
4Huberfeld G, Kubis N, Lot G, et al. Woimant F G20210A prothrombin gene mutation in two siblings with cerebral venous thrombosis. Neurology, 1998, 51 ( 1 ): 316-317.
5Akatsu H, Vaysburd M, Fervenza F, et al. Cerebral venous thrombosis in nephrotic syndrome. Clin Nephrol, 1997, 48(5): 317-320.
6de Bruijn SF, Stam J, Koopman MM, et al. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ, 1998, 316(7131): 589-592.
7Nagai S, Horie Y, Akai T, et al. Superior sagittal sinus thrombosis associated with primary antiphospholipid syndrome -- case report. Neuroi Med Chir(Tokyo), 1998, 38(1): 34-39.
8Hauser D, BarAlai N, Zahsh M, et al. Bilateral papilledema with retinal hemorrhages in association with cerebral venous sinus thrombosis and paroxysmal nocturnal hemoglobinuria. Am J Ophthalmol, 1996, 122(4): 592-593.
9Martinelli I, Landi G, Merati G, et al. Factor V gene mutation is a risk factor for cerebral venous thrombosis. Thromb Haemost, 1996, 75(3):393-394.
10Pugliese D, Nicoletti G, Andreula C, et al. Combined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis -- a case report. Angiology,1998, 49(5): 399-401.
